Literature DB >> 16299311

Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.

Timothy F Murphy1, Aimee L Brauer, Christoph Aebi, Sanjay Sethi.   

Abstract

Moraxella catarrhalis is an important human mucosal pathogen causing otitis media in children and lower respiratory tract infection in adults with chronic obstructive pulmonary disease (COPD). Little is known about the mucosal antibody response to M. catarrhalis in adults with COPD. In this study, 10 pairs of well-characterized sputum supernatant samples from adults with COPD who had acquired and subsequently cleared M. catarrhalis from their respiratory tracts were studied in detail in an effort to begin to elucidate potentially protective immune responses. Flow cytometry analysis was used to study the distribution of immunoglobulin isotypes in paired preacquisition and postclearance sputum samples. The results showed that immunoglobulin A (IgA) is the predominant M. catarrhalis-specific immunoglobulin isotype and that the sputum IgA contains a secretory component, indicating that it is locally produced at the mucosal site. Most patients made new sputum IgA responses to the adhesins UspA1 and Hag, along with the surface protein UspA2. A smaller proportion of patients made new sputum IgA responses to the iron-regulated proteins TbpB and CopB and to lipooligosaccharide. These results have important implications in understanding the mucosal immune response to M. catarrhalis in the setting of COPD and in elucidating the elements of a protective immune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299311      PMCID: PMC1307080          DOI: 10.1128/IAI.73.12.8161-8166.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  Chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

2.  Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.

Authors:  N Soler; S Ewig; A Torres; X Filella; J Gonzalez; A Zaubet
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

Review 3.  The role of infection in COPD.

Authors:  R Wilson
Journal:  Chest       Date:  1998-04       Impact factor: 9.410

4.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.

Authors:  Timothy F Murphy; Aimee L Brauer; Brydon J B Grant; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

6.  Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.

Authors:  E R Lafontaine; L D Cope; C Aebi; J L Latimer; G H McCracken; E J Hansen
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

8.  The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

Authors:  D Chen; V Barniak; K R VanDerMeid; J C McMichael
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

9.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

Authors:  E Monsó; J Ruiz; A Rosell; J Manterola; J Fiz; J Morera; V Ausina
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

10.  Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults.

Authors:  Patricia Stutzmann Meier; Nadja Heiniger; Rolf Troller; Christoph Aebi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more
  25 in total

Review 1.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

2.  Expression of IgA Proteases by Haemophilus influenzae in the Respiratory Tract of Adults With Chronic Obstructive Pulmonary Disease.

Authors:  Timothy F Murphy; Charmaine Kirkham; Megan M Jones; Sanjay Sethi; Yong Kong; Melinda M Pettigrew
Journal:  J Infect Dis       Date:  2015-05-20       Impact factor: 5.226

3.  Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Jennifer L Sedillo; Maria Labandeira-Rey; Cassie A Laurence; Wei Wang; James A Richardson; Lauren O Bakaletz; Eric J Hansen
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

4.  Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.

Authors:  Timothy F Murphy; Aimee L Brauer; Melinda M Pettigrew; Eric R LaFontaine; Hervé Tettelin
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

5.  Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.

Authors:  Thuan Tong Tan; Jens Jørgen Christensen; Morten Hanefeld Dziegiel; Arne Forsgren; Kristian Riesbeck
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

6.  A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein.

Authors:  Ahmed S Attia; Eric J Hansen
Journal:  J Bacteriol       Date:  2006-09-08       Impact factor: 3.490

7.  Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells.

Authors:  Rachel Balder; Thomas M Krunkosky; Chi Q Nguyen; Lacey Feezel; Eric R Lafontaine
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

8.  Virulence-associated trimeric autotransporters of Haemophilus parasuis are antigenic proteins expressed in vivo.

Authors:  Alex Olvera; Sonia Pina; Marta Pérez-Simó; Simone Oliveira; Albert Bensaid
Journal:  Vet Res       Date:  2009-12-10       Impact factor: 3.683

Review 9.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

10.  Moraxella catarrhalis expresses an unusual Hfq protein.

Authors:  Ahmed S Attia; Jennifer L Sedillo; Wei Wang; Wei Liu; Chad A Brautigam; Wade Winkler; Eric J Hansen
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.